SEC 13F Intelligence

First Fiduciary Investment Counsel, Inc. / NVS

First Fiduciary Investment Counsel, Inc.’s Novartis AG Position

Does First Fiduciary Investment Counsel, Inc. own Novartis AG (NVS)? Yes — 98.8K shares worth $15M (+3.04% of its 13F portfolio) as of Q1 2026, down from 135.4K shares the prior filed quarter.

Position Value
$15M
Q1 2026
Shares
98.8K
% of Portfolio
+3.04%
Quarters Held
29
currently held

Position History NVS

Reported value by quarter
Q1 ’19: $22MQ1 ’19Q2 ’19: $17MQ3 ’19: $16MQ4 ’19: $18MQ1 ’20: $15MQ1 ’20Q2 ’20: $16MQ3 ’20: $17MQ4 ’20: $19MQ1 ’21: $15MQ1 ’21Q2 ’21: $15MQ3 ’21: $14MQ4 ’21: $15MQ1 ’22: $15MQ1 ’22Q2 ’22: $14MQ3 ’22: $12MQ4 ’22: $14MQ1 ’23: $14MQ1 ’23Q2 ’23: $15MQ3 ’23: $15MQ4 ’23: $15MQ1 ’24: $14MQ1 ’24Q2 ’24: $15MQ3 ’24: $16MQ4 ’24: $14MQ1 ’25: $15MQ1 ’25Q2 ’25: $17MQ3 ’25: $18MQ4 ’25: $19MQ1 ’26: $15MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202698.8K$15M+3.04%
Q4 2025135.4K$19M+3.62%
Q3 2025136.5K$18M+3.41%
Q2 2025136.8K$17M+3.28%
Q1 2025136.4K$15M+3.26%
Q4 2024142.1K$14M+2.81%
Q3 2024140.5K$16M+3.23%
Q2 2024141.6K$15M+3.27%
Q1 2024141.1K$14M+2.83%
Q4 2023144.0K$15M+3.21%
Q3 2023145.7K$15M+3.48%
Q2 2023150.9K$15M+3.31%
Q1 2023154.3K$14M+3.14%
Q4 2022158.4K$14M+3.15%
Q3 2022160.8K$12M+3.07%
Q2 2022161.7K$14M+3.09%
Q1 2022169.4K$15M+2.90%
Q4 2021170.2K$15M+2.64%
Q3 2021167.4K$14M+2.67%
Q2 2021169.3K$15M+2.96%
Q1 2021173.6K$15M+2.83%
Q4 2020196.7K$19M+3.48%
Q3 2020193.0K$17M+3.49%
Q2 2020186.9K$16M+2.86%
Q1 2020187.6K$15M+4.10%
Q4 2019188.5K$18M+3.33%
Q3 2019182.7K$16M+3.36%
Q2 2019190.2K$17M+3.67%
Q1 2019224.2K$22M+3.99%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See First Fiduciary Investment Counsel, Inc.’s full portfolio or all institutional holders of NVS.